Below are the most recent publications written about "Bridged Bicyclo Compounds" by people in Profiles.
-
Rajpal S, Katikaneni P, Deshotels M, Pardue S, Glawe J, Shen X, Akkus N, Modi K, Bhandari R, Dominic P, Reddy P, Kolluru GK, Kevil CG. Total sulfane sulfur bioavailability reflects ethnic and gender disparities in cardiovascular disease. Redox Biol. 2018 05; 15:480-489.
-
Jadhav VD, Duerfeldt AS, Blagg BS. Design, synthesis, and biological activity of bicyclic radester analogues as Hsp90 inhibitors. Bioorg Med Chem Lett. 2009 Dec 15; 19(24):6845-50.
-
Chen CL, Sangiah S, Roder JD, Chen H, Berlin KD, Garrison GL, Scherlag BJ, Lazzara R. Pharmacokinetics and plasma protein binding of the new potent class III antiarrhythmic agent 3-[4-(1H-imidazol-1-yl)benzoyl]-7-isopropyl-3, 7-diazabicyclo[3.3.1]nonane dihydroperchlorate. Arzneimittelforschung. 1995 Jun; 45(6):670-5.
-
Fazekas T, Scherlag BJ, Carlsson L, Mabo P, Patterson E, Berlin KD, Lazzara R. Electrophysiological characterization of a novel class III antiarrhythmic agent, GLG-V-13 in the mammalian heart. Acta Physiol Hung. 1995; 83(1):13-30.
-
Chen CL, Sangiah S, Yu CA, Chen H, Berlin KD, Garrison GL, Scherlag BJ, Lazzara R. Effects of novel antiarrhythmic agents, BRB-I-28 and its derivatives, on the heart mitochondrial respiratory chain and sarcoplasmic reticulum Ca(2+)-ATPase. Res Commun Mol Pathol Pharmacol. 1994 Aug; 85(2):193-208.
-
Patterson E, Scherlag BJ, Berlin KD, Lazzara R. Electrophysiologic actions of BRB-I-28 in ischemically injured canine myocardium. J Cardiovasc Pharmacol. 1993 Apr; 21(4):637-46.
-
Fazekas T, Scherlag BJ, Mabo P, Berlin KD, Garrison GL, Chen CL, Sangiah S, Patterson E, Lazzara R. The comparative antiarrhythmic and proarrhythmic activity of a 3,7-diheterobicyclo[3.3.1]nonane, BRB-I-28, and lidocaine in the 1-4-day-old infarcted dog heart. Acta Physiol Hung. 1993; 81(3):289-99.
-
Chen CL, Lesseley BA, Clarke CR, Roder JD, Sangiah S, Berlin KD, Garrison GL, Scherlag BJ, Lazzara R, Patterson E. High-performance liquid chromatographic determination of BRB-I-28, a novel antiarrhythmic agent, in dog plasma and urine. J Chromatogr. 1992 Dec 02; 583(2):274-9.
-
Chen CL, Sangiah S, Patterson E, Berlin KD, Garrison GL, Dunn W, Nan Y, Scherlag BJ, Lazzara R. Effects of BRB-I-28, a novel antiarrhythmic agent, and its derivatives on cardiac Na+,K(+)-ATPase, Mg(2+)-ATPase activities and contractile force. Res Commun Chem Pathol Pharmacol. 1992 Oct; 78(1):3-16.
-
Pugsley MK, Walker MJ, Garrison GL, Howard PG, Lazzara R, Patterson E, Penz WP, Scherlag BJ, Berlin KD. The cardiovascular and antiarrhythmic properties of a series of novel sparteine analogs. Proc West Pharmacol Soc. 1992; 35:87-91.